The ultra-right nominee for director of our nation’s agency on public health has a notoriously anti-gay and anti-PLHIV history.
Join "Rhythm is a Dancer" singer Thea Austin at the old Catch One nightclub in Los Angeles, to support alternative medicine clinic serving people with HIV.
Pittsburgh suburbs are reporting an alarming spike of HIV and gonorrhea instances — which has health officials scrambling for a solution.
While promoting the AIDS drama 1984, Gotham actor Cory Michael Smith comes out as queer.
A drug used to treat heart failure apparently blocks HIV-1 reactivation.
We've come a long way baby.
Circumcision has been a go to for HIV prevention, especially in Africa. One researcher questions its validity.
The FDA has approved a years-in-development treatment for multidrug-resistant HIV, a boon for those who've become resistant to most or all available HIV meds.
The HIV prevention drug still carries a heavy stigma among people of color.
125 Milwaukeean high schoolers, adults and children have become infected with HIV, syphilis or both — in what is being reported as “one of the largest sexually transmitted infection” clusters ever identified.
A question many of us ponder daily.
The "pharma bro" is going to sit behind bars for securities fraud.
Get more sleep. More sleep means better sex.
Experts aim to halve the number of deaths from a type of meningitis by changing drug treatment as a result of a new medical study. The fungal infection cryptococcal meningitis is responsible for more than 180,000 deaths per year worldwide, mainly in HIV-infected patients. Show More Summary
Researchers say they can now produce a vast library of unique cyclic compounds, some with the capacity to interrupt specific protein-protein interactions that play a role in disease. The new compounds have cyclic structures that give them stability and enhance their ability to bind to their targets.
Researchers have found a mechanism for making HIV come out of hiding and become susceptible to anti-HIV drugs.
David Cooper played a crucial role in developing the drug trials for many of the HIV medications currently on the market and saving lives today.
It happened: you tested positive for HIV. What's next?
Researchers from New York’s Aaron Diamond AIDS Research Center presented a new long-lasting PrEP pill at the 25th Conference on Retroviruses and Opportunistic Infections (CROI).